Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-ne...
November 15, 2026
Share
Survival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.